A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma. (Q55068144)
Jump to navigation
Jump to search
scientific article published on 15 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma. |
scientific article published on 15 January 2015 |
Statements
A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma. (English)
1 reference
1 reference
Dirk Schadendorf
1 reference
Paolo A Ascierto
1 reference
Antoni Ribas
1 reference
F Stephen Hodi
1 reference
Jacob Schachter
1 reference
Christian Blank
1 reference
Reinhard Dummer
1 reference
Igor Puzanov
1 reference
Omid Hamid
1 reference
Caroline Robert
1 reference
Anna Pavlick
1 reference
Rene Gonzalez
1 reference
Lee D Cranmer
1 reference
Steven J O’Day
1 reference
April K S Salama
1 reference
Nicole Xiaoyun Li
1 reference
Wei Zhou
1 reference
Joy Lis
1 reference
Scot Ebbinghaus
1 reference
Peter S Kang
1 reference
15 January 2015
1 reference
13
1 reference
Suppl 1
1 reference
O5-O5
1 reference
Identifiers
1 reference